Whether or not Brexit agreement, upon the departure of the united kingdom of the eu active substances as manufactured in that country shall be considered as active substances imported.
In accordance with european rules, it requires that drug manufacturers use only active substances as manufactured according to the good manufacturing practices starting materials shall be subject to inspection by the authorities of the eu as a third country.
Similarly in the previous case, upon the departure of the united kingdom of the eu drugs made in that country shall be treated as imported medicines. to continue with a provision to the eu/eea Brexit as before, by 30 march 2019 should have adapted the registration of pharmaceuticals manufactured in the united kingdom, including in the same a TAC and a liberator of the drug located in the eea.
Otherwise, the competent authorities of the eu/eea will ensure that the import of drugs on its territory is subject to authorization in accordance with european standards. Will be subject to inspection by the authorities of the eu as a third country.
Whether or not Brexit agreement, after the effective implementation of the united kingdom of the eu drugs from this country must be imported by a pharmaceutical laboratory importer.
When the UK leaves the EU are there going to be problems with drug availability?
The authorities of the eu have months to report to the holders of marketing authorisations for the legal obligations on pharmacovigilance, ownership, manufacture, etc. Currently, the majority of medicines have successfully resolved. Those that have not been solved and fail to do so in time, you will see suspended their authorisations on 29 march 2019.
In parallel, together with all member States and the european medicines agency (EMA), for this there are risks or shortcomings condoms or as a result of therapeutic Brexit. The potential risks and are scarce and this is looking for alternatives so that there are in practice such problems.
If you browse a veterinary medicine, european and national legislation provides that
The exceptional prescribe a veterinary medicine of another member state or of medicinal products for human use authorized in Spain.
Thanks for your comments.